Edition:
United Kingdom

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

2.70USD
21 Sep 2018
Change (% chg)

$-0.06 (-2.17%)
Prev Close
$2.76
Open
$2.76
Day's High
$2.79
Day's Low
$2.63
Volume
24,127
Avg. Vol
34,406
52-wk High
$20.40
52-wk Low
$2.03

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -1.687
Mar '18 0.00 -2.068
FY 2017 Dec '17 0.00 -3.220
Sep '17 0.00 -2.576
Jun '17 0.00 -2.319
Mar '17 0.00 -2.407
FY 2016 Dec '16 0.00 -3.436
Sep '16 0.00 -4.260
Jun '16 0.00 -4.928
Mar '16 0.00 9.097
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-18 1 -0.83 -0.83 -0.83 -2.20
Quarter Ending Dec-18 1 -0.87 -0.87 -0.87 -2.30
Year Ending Dec-18 1 -3.59 -3.59 -3.59 -8.70
Year Ending Dec-19 1 -3.03 -3.03 -3.03 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.93 32.76
P/E High - Last 5 Yrs. -- 40.65 45.44
P/E Low - Last 5 Yrs. -- 23.69 24.26
Beta 1.02 0.90 0.89
Price to Sales (TTM) -- 3.93 5.74
Price to Book (MRQ) 2.13 4.88 5.00
Price to Tangible Book (MRQ) 2.60 5.70 6.57
Price to Cash Flow (TTM) -- 22.85 23.29
% Owned Institutions 7.03 1.23 2.21

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.35 5.22
Payout Ratio(TTM) -- 45.85 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.27 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 4.77 5.64
Sales - 5 Yr. Growth Rate -- 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 52.94 17.61 20.61
EPS (TTM) vs TTM 1 Yr. Ago -33.17 -- --
EPS - 5 Yr. Growth Rate -- 9.75 10.66
Capital Spending - 5 Yr. Growth Rate -9.41 15.37 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.22
Current Ratio (MRQ) 5.88 2.94 3.03
LT Debt to Equity (MRQ) 0.03 10.03 12.51
Total Debt to Equity (MRQ) 0.06 14.07 16.85
Interest Coverage (TTM) -- 35.79 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.71 54.37
Gross Margin - 5 Yr. Avg. -- 52.10 52.16
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.48 10.68
Operating Margin (TTM) -- 14.31 4.33
Operating Margin - 5 Yr. Avg. -- 14.43 6.11
Pre-Tax Margin (TTM) -- 14.80 5.18
Pre-Tax Margin - 5 Yr. Avg. -- 14.82 6.51
Net Profit Margin (TTM) -- 11.05 1.48
Net Profit Margin - 5 Yr. Avg. -- 11.12 2.78
Effective Tax Rate (TTM) -- 23.22 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.48 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 952,972,583 860,305,024
Net Income/Employee (TTM) -725,656 112,116,760 101,198,978
Receivable Turnover (TTM) -- 5.72 5.87
Inventory Turnover (TTM) -- 2.63 3.41
Asset Turnover (TTM) 0.00 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -90.79 11.58 11.13
Return on Assets - 5 Yr. Avg. -75.22 12.95 12.40
Return on Investment (TTM) -103.68 15.07 14.61
Return on Investment - 5 Yr. Avg. -115.63 16.90 16.13
Return on Equity (TTM) -105.20 16.59 16.33
Return on Equity - 5 Yr. Avg. -127.41 17.97 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 80.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellectar Biosciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.19%
# of Holders: 23
Total Shares Held: 150,809
3 Mo. Net Change: 22,272
# New Positions: 4
# Closed Positions: 1
# Increased Positions: 8
# Reduced Positions: 2
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.